Smith & Wesson Brands, Inc. (SWBI) · Oct 21, 2026 · Acquisition
$160M acquisition — ~9M shares plus $37.5M cash; FY27 EPS accretion ~$0.07
Smith & Wesson’s Savage acquisition expands hunting exposure and is immediately accretive, but the deal brings major equity dilution and integration risk.
Smith & Wesson is emerging from a firearms-demand recovery while pursuing broader exposure beyond its handgun core and into adjacent long-gun categories. Its latest quarter showed 32% sales growth, and its stated strategy emphasizes expanding into complementary markets.
This is a meaningful strategic expansion, not a bolt-on housekeeping deal. Smith & Wesson has completed the acquisition of Savage, a major hunting, bolt-action rifle and shotgun manufacturer. The transaction directly fills a gap in Smith & Wesson’s portfolio and gives it a much stronger position in hunting and precision shooting. The filing says, “The transaction combines two iconic American firearm manufacturers with leading capabilities across distinct segments of the firearms market.” 〔0〕
| Measure | Filing figure |
|---|---|
| Transaction value | $160.0M base value; approximately $164.9M adjusted value (Transaction Details; Item 1.01) |
| Savage trailing-12-month sales | Approximately $160M (Financial Information) |
| Cash consideration | $37.5M in the release; $42.4M including estimated closing adjustments in Item 1.01 (Transaction Details; Item 1.01) |
| Stock consideration | 8,993,968 shares, approximately 19.99% of pre-closing shares (Item 1.01) |
| Expected full-year EPS accretion | Approximately $0.07 before synergies; approximately $0.10 after initial synergies (Financial Information; Transaction Details) |
| Expected incremental EBITDAS | Approximately $18M annually (Financial Information) |
| Initial annual run-rate synergies | Approximately $2.5M (Transaction Details) |
| Pro forma net leverage | 1.16x (Transaction Details) |
| JDH ownership after closing | 16.7% (Transaction Details) |
The deal clears the basic financial hurdle on management’s numbers. Management projects immediate full-year EPS accretion of roughly $0.07 before synergies and $0.10 after them, while expecting about $18 million of incremental annual EBITDAS. That makes this more than a strategic repositioning: the acquisition is presented as earnings-accretive from the start. The filing states, “Savage generated approximately $160million of net sales for the twelve-month period ending September 30, 2026.”
The balance sheet appears capable of absorbing the transaction, but shareholders fund most of it with dilution. The cash portion is modest relative to the purchase price, and pro forma net leverage of 1.16x is not aggressive. The trade-off is the issuance of nearly 9 million shares—about one-fifth of the pre-deal share count—which gives the seller a substantial ownership position. JDH will own 16.7% of the combined company and receive board representation, making it a meaningful long-term influence rather than a passive seller. The filing states, “Following the closing, JDH owns 16.7% of Smith & Wesson’s outstanding common stock.” 〔1〕
The strategic logic is credible, but the evidence is still largely pro forma. The companies share dealers, distributors and end customers, which could support cross-selling and operating efficiencies. However, Savage’s financial information was derived from its own accounting and the acquired-business financial statements and pro forma figures have not yet been filed. That leaves the quality of earnings, working-capital needs and the true cost of integration less tested than the headline accretion suggests.
Bottom line: This advances Smith & Wesson’s diversification strategy while adding near-term earnings power without materially stretching leverage. The important caveat is that the value creation depends on integrating Savage successfully and making the large equity issuance worthwhile.
Savage financials and pro forma filing within 71 days
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!